Patients with peripheral arterial disease in the CHARISMA trial.
Conclusion Dual therapy provided some benefit over aspirin alone in PAD patients for the rate of MI and the rate of hospitalization for ischaemic events, at the cost of an increase in minor bleeding.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario